Fibrotic-Like Pulmonary Radiographic Patterns Are Not Associated With Adverse Outcomes in COVID-19 Chronic Critical Illness
Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved..
OBJECTIVES: Pulmonary fibrosis is a feared complication of COVID-19. To characterize the risks and outcomes associated with fibrotic-like radiographic abnormalities in patients with COVID-19-related acute respiratory distress syndrome (ARDS) and chronic critical illness.
DESIGN: Single-center prospective cohort study.
SETTING: We examined chest CT scans performed between ICU discharge and 30 days after hospital discharge using established methods to quantify nonfibrotic and fibrotic-like patterns.
PATIENTS: Adults hospitalized with COVID-19-related ARDS and chronic critical illness (> 21 d of mechanical ventilation, tracheostomy, and survival to ICU discharge) between March 2020 and May 2020.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We tested associations of fibrotic-like patterns with clinical characteristics and biomarkers, and with time to mechanical ventilator liberation and 6-month survival, controlling for demographics, comorbidities, and COVID-19 therapies. A total of 141 of 616 adults (23%) with COVID-19-related ARDS developed chronic critical illness, and 64 of 141 (46%) had a chest CT a median (interquartile range) 66 days (42-82 d) after intubation. Fifty-five percent had fibrotic-like patterns characterized by reticulations and/or traction bronchiectasis. In adjusted analyses, interleukin-6 level on the day of intubation was associated with fibrotic-like patterns (odds ratio, 4.40 per quartile change; 95% CI, 1.90-10.1 per quartile change). Other inflammatory biomarkers, Sequential Organ Failure Assessment score, age, tidal volume, driving pressure, and ventilator days were not. Fibrotic-like patterns were not associated with longer time to mechanical ventilator liberation or worse 6-month survival.
CONCLUSIONS: Approximately half of adults with COVID-19-associated chronic critical illness have fibrotic-like patterns that are associated with higher interleukin-6 levels at intubation. Fibrotic-like patterns are not associated with longer time to liberation from mechanical ventilation or worse 6-month survival.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
Critical care medicine - 51(2023), 11 vom: 01. Nov., Seite e209-e220 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Madahar, Purnema [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 31.10.2023 Date Revised 01.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1097/CCM.0000000000005954 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357959140 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357959140 | ||
003 | DE-627 | ||
005 | 20231226073722.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/CCM.0000000000005954 |2 doi | |
028 | 5 | 2 | |a pubmed24n1193.xml |
035 | |a (DE-627)NLM357959140 | ||
035 | |a (NLM)37294143 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Madahar, Purnema |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fibrotic-Like Pulmonary Radiographic Patterns Are Not Associated With Adverse Outcomes in COVID-19 Chronic Critical Illness |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.10.2023 | ||
500 | |a Date Revised 01.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. | ||
520 | |a OBJECTIVES: Pulmonary fibrosis is a feared complication of COVID-19. To characterize the risks and outcomes associated with fibrotic-like radiographic abnormalities in patients with COVID-19-related acute respiratory distress syndrome (ARDS) and chronic critical illness | ||
520 | |a DESIGN: Single-center prospective cohort study | ||
520 | |a SETTING: We examined chest CT scans performed between ICU discharge and 30 days after hospital discharge using established methods to quantify nonfibrotic and fibrotic-like patterns | ||
520 | |a PATIENTS: Adults hospitalized with COVID-19-related ARDS and chronic critical illness (> 21 d of mechanical ventilation, tracheostomy, and survival to ICU discharge) between March 2020 and May 2020 | ||
520 | |a INTERVENTIONS: None | ||
520 | |a MEASUREMENTS AND MAIN RESULTS: We tested associations of fibrotic-like patterns with clinical characteristics and biomarkers, and with time to mechanical ventilator liberation and 6-month survival, controlling for demographics, comorbidities, and COVID-19 therapies. A total of 141 of 616 adults (23%) with COVID-19-related ARDS developed chronic critical illness, and 64 of 141 (46%) had a chest CT a median (interquartile range) 66 days (42-82 d) after intubation. Fifty-five percent had fibrotic-like patterns characterized by reticulations and/or traction bronchiectasis. In adjusted analyses, interleukin-6 level on the day of intubation was associated with fibrotic-like patterns (odds ratio, 4.40 per quartile change; 95% CI, 1.90-10.1 per quartile change). Other inflammatory biomarkers, Sequential Organ Failure Assessment score, age, tidal volume, driving pressure, and ventilator days were not. Fibrotic-like patterns were not associated with longer time to mechanical ventilator liberation or worse 6-month survival | ||
520 | |a CONCLUSIONS: Approximately half of adults with COVID-19-associated chronic critical illness have fibrotic-like patterns that are associated with higher interleukin-6 levels at intubation. Fibrotic-like patterns are not associated with longer time to liberation from mechanical ventilation or worse 6-month survival | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Capaccione, Kathleen M |e verfasserin |4 aut | |
700 | 1 | |a Salvatore, Mary M |e verfasserin |4 aut | |
700 | 1 | |a Short, Briana |e verfasserin |4 aut | |
700 | 1 | |a Wahab, Romina |e verfasserin |4 aut | |
700 | 1 | |a Abrams, Darryl |e verfasserin |4 aut | |
700 | 1 | |a Parekh, Madhavi |e verfasserin |4 aut | |
700 | 1 | |a Geleris, Joshua D |e verfasserin |4 aut | |
700 | 1 | |a Furfaro, David |e verfasserin |4 aut | |
700 | 1 | |a Anderson, Michaela R |e verfasserin |4 aut | |
700 | 1 | |a Zucker, Jason |e verfasserin |4 aut | |
700 | 1 | |a Brodie, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Cummings, Matthew J |e verfasserin |4 aut | |
700 | 1 | |a O'Donnell, Max |e verfasserin |4 aut | |
700 | 1 | |a McGroder, Claire F |e verfasserin |4 aut | |
700 | 1 | |a Wei, Ying |e verfasserin |4 aut | |
700 | 1 | |a Garcia, Christine K |e verfasserin |4 aut | |
700 | 1 | |a Baldwin, Matthew R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical care medicine |d 1973 |g 51(2023), 11 vom: 01. Nov., Seite e209-e220 |w (DE-627)NLM000002631 |x 1530-0293 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2023 |g number:11 |g day:01 |g month:11 |g pages:e209-e220 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/CCM.0000000000005954 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 51 |j 2023 |e 11 |b 01 |c 11 |h e209-e220 |